CAS: 339186-68-4 - Matuzumab
Formula:Unspecified
- Sinonimi:
- Emd 62000
- Emd 7200
- Emd 72000
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (human-mouse monoclonal 425 γ1-chain), disulfide with human-mouse monoclonal 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor) (humanized MAb 425 γ1-chain), disulfide with humanized MAb 425 κ-chain, dimer
- Immunoglobulin G1, anti-(human epidermal growth factor receptor)(humanized MAb 425 gamma-1 chain), disulfide with humanized MAb 425 kappa-chain, dimer
- KGaA
- Matuzumab [INN]
- Merck KGaA
- Matuzumab
- Vedi altri sinonimi
| Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
|---|---|---|---|---|
 | Matuzumab REF: TM-T9922CAS: 339186-68-4 | 95% | 212,00 €~1.568,00 € | Mar 07 Gen 25 |
 | Matuzumab - 10 mg/ml REF: 3D-BM165590CAS: 339186-68-4 | Min. 95 Area-% | 1.111,00 €~1.707,00 € | Mer 15 Gen 25 |
Matuzumab
CAS:339186-68-4
Matuzumab (EMD 72000) is a humanized monoclonal antibody targeting EGFR that can be used to …
Purezza:
95%
Colore e forma:
Liquid
Peso molecolare:
145.9 kDa
Ref: TM-T9922
| 1mg | 212,00 € | ||
| 5mg | 541,00 € | ||
| 10mg | 760,00 € | ||
| 25mg | 1.160,00 € | ||
| 50mg | 1.568,00 € |
Consegna stimata in Stati Uniti, il Martedì 07 Gennaio 2025
Matuzumab - 10 mg/ml
CAS:339186-68-4
Intereferes with EGFR homodimerisation; cancer therapy
Purezza:
Min. 95 Area-%
Colore e forma:
Powder
Ref: 3D-BM165590
| 1mg | 1.111,00 € | ||
| 2mg | 1.366,00 € | ||
| 5mg | 1.707,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 15 Gennaio 2025
